← Evidence map

ArticleCureus2025

Adding Ezetimibe to High-Intensity Statin at the Time of Admission in Patients With Acute Coronary Syndrome: Results From the Optimization of Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome (OLA) Study.

Kunal Mahajan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Adding Ezetimibe to High-Intensity Statin at the Time of Admission in Patients With Acute Coronary Syndrome: Results From the Optimization of Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome (OLA) Study. | Socratic